Schedule 13G ownership disclosure

Halozyme Therapeutics Inc

Security class unavailable · CUSIP: 40637H109

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
13,306,154
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001033427-18-000018
Form type
SC 13G/A
Filer
HALOZYME THERAPEUTICS, INC.
CIK
CIK 1159036
Filed
Feb 06, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub